4th Annual Lysosomal Disease Summit
2–3 October 2026 • Melbourne, Australia
Plan now to join Australian and international faculty for the 4th Annual Lysosomal Disease Summit. Join clinicians, researchers, industry leaders, and patient advocates to collaborate and unite to advance diagnostics and therapeutic innovation, and promote compassionate, patient-centred care for all individuals living with lysosomal diseases.
Keynote Speakers
Two internationally recognized leaders in lysosomal disease research and clinical care will headline the 4th Annual Lysosomal Disease Summit.
Professor Michael Gelb, PhD
University of Washington, Seattle, USA
A chemist by training, Professor Gelb has led pioneering work on assays that have expanded newborn screening for lysosomal diseases.
Keynote Topic:
Newborn Screening and Whole Genome Sequencing
Professor Jeff Szer, MD
Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Australia
Professor Szer is a clinical haematologist specializing in stem cell transplantation and non-malignant haematologic disorders. His work includes significant contributions to the understanding and treatment of Gaucher disease.
Keynote Topic:
Latest Developments and Emerging Breakthroughs in Gaucher Disease
Additional programme details will be announced in the coming months!
What to Expect in 2026
- Expert-led sessions on diagnostics, treatment development, and clinical insights
- High-scoring oral and poster abstracts from global researchers
- Panels, roundtables, and cross-disciplinary discussions
- APAC-focused and international perspectives on lysosomal disease care
Who Should Attend
The Summit welcomes professionals working across the lysosomal and metabolic disease landscape, including:
- Clinicians involved in diagnosis, treatment planning, and long-term patient management
- Researchers and scientists advancing basic, translational, and clinical studies
- Early-career investigators, trainees, and fellows seeking exposure to current research, mentorship, and global collaboration
- Industry partners contributing to therapeutic development, regulatory strategy, medical affairs, or clinical operations
- Advocacy leaders and patient-group representatives supporting education, access, and community engagement
- Allied health practitioners involved in multidisciplinary care
Review the 2025 Summit
View the 2025 agenda, meet course directors, and discover the sponsors who made this event possible.
We respectfully acknowledge the Traditional Owners of the land on which the Lysosomal Disease Summit will take place, the Wurundjeri Woi Wurrung people of the Kulin Nation, and pay our respects to their Elders past and present. We recognise their continuing connection to land, waters, and culture.
Thank You, 2025 Summit Sponsors
